Literature DB >> 13091821

[Results of observations of 36 cases of leukotomies].

W BARTSCH.   

Abstract

Keywords:  PAIN/surgery; PSYCHOSURGERY

Mesh:

Year:  1953        PMID: 13091821     DOI: 10.1007/bf01227062

Source DB:  PubMed          Journal:  Acta Neuroveg (Wien)        ISSN: 0375-9245


× No keyword cloud information.
  9 in total

1.  Pain of organic disease relieved by prefrontal lobotomy.

Authors:  W FREEMAN; J W WATTS
Journal:  Lancet       Date:  1946-06-29       Impact factor: 79.321

2.  Unilateral prefrontal lobotomy with relief of ipsilateral, contralateral, and bilateral pain; a preliminary report.

Authors:  J E SCARFF
Journal:  J Neurosurg       Date:  1948-05       Impact factor: 5.115

3.  [Pathogenesis and therapy of the phantom pain in amputees].

Authors:  W BARTSCH
Journal:  Arztl Wochensch       Date:  1952-07-04

4.  [Not Available].

Authors:  M A ZEHNDER
Journal:  Schweiz Med Wochenschr       Date:  1949-03-05

5.  [Not Available].

Authors:  A STENDER
Journal:  Dtsch Z Nervenheilkd       Date:  1949

6.  [Phantom limb pain].

Authors:  W SORGO
Journal:  Acta Neurochir (Wien)       Date:  1951       Impact factor: 2.216

7.  [Problems of psychosurgery in psychiatric disease and intractable pain].

Authors:  L B KALINOWSKY
Journal:  Dtsch Med Wochenschr       Date:  1950-09-08       Impact factor: 0.628

8.  [Cerebral anatomy and physiology; changes of psychic function after prefrontal lobotomy].

Authors:  H J BARAHONA-FERNANDES
Journal:  Nervenarzt       Date:  1952-03       Impact factor: 1.214

9.  [Psychosurgery in intractable pain].

Authors:  H KRAYENBUHL; W A STOLL
Journal:  Acta Neurochir (Wien)       Date:  1950       Impact factor: 2.216

  9 in total
  2 in total

1.  [Clinical and anatomical findings in stereotactic pain operations on the thalamus].

Authors:  R HASSLER; T RIECHERT
Journal:  Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr       Date:  1959

2.  [The central pain systems].

Authors:  R HASSLER
Journal:  Acta Neurochir (Wien)       Date:  1960-11-23       Impact factor: 2.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.